Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MediGuide's medical positioning system and guided catheter:

This article was originally published in Clinica

Executive Summary

MediGuide has CE marked its Medical Positioning System (MPS) and MPS-enabled Guided Measurement Catheter (GMC) for sale in Europe. The MPS is a navigation system designed to be used in various minimally-invasive procedures. When equipped on an X-ray imaging cath lab system, the MPS can aid the intravascular evaluation of coronary anatomy. It allows real-time tip positioning and navigation of a diagnostic or therapeutic invasive device (if equipped with an MPS sensor) for coronary or cardiac intervention. The GMC, also CE marked by the Haifa, Israel company, is the first MPS-enabled catheter. It is intended to be used in conjunction with conventional X-ray angiography systems equipped with MPS, to enable tip positioning and navigation, quantitative length measurement, 3D lumen reconstruction, qualitative 3D foreshortening indication and landmarking in patients who are candidates for coronary angiography and/or percutaneous coronary intervention.

You may also be interested in...



COVID-19 Lockdown: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

Moderna Stands Alone With Single-Antigen Approach To COVID-19 Vaccine

Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.

Kansas City TCM Firm Persists With COVID-19 Claims Following US Regulators' Warning

Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.

Topics

UsernamePublicRestriction

Register

MT050497

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel